☀ New York | Friday November 20, 2026 | Sign In
⚡ TRENDING NOW

Ireland tackles osteoporosis with new approach

Ireland tackles osteoporosis with new approach - osteoporosis treatment
Two specialists spoke at the Irish Osteoporosis Society’s 2026 Annual Medical Conference.

The importance of identifying and managing risk factors early cannot be overstated when tackling Ireland’s osteoporosis challenge, experts emphasized at the Irish Osteoporosis Society’s 2026 Annual Medical Conference. Two specialists from Clontarf Hospital, Dublin, Senior Physiotherapist Anne-Marie Seddon and Dietitian Manager Sinead Shanley, highlighted how sarcopaenia (the decline in muscle mass and function) and osteoporosis (reduced bone density) operate as a linked system, often occurring together in what’s termed osteosarcopaenia.

Muscles exert mechanical force on bones during contraction, which strengthens skeletal structure. When muscle weakness develops, it not only speeds up bone deterioration but also increases susceptibility to falls and fractures, the presenters explained. Beyond posing a fall hazard, sarcopaenia serves as an indicator that osteoporosis may be emerging.

Clontarf Hospital’s screening and treatment approach follows the European Working Group on Sarcopaenia in Older People (EWGSOP) framework, which guides detection, diagnosis, and severity assessment. Seddon described how the hospital’s protocol was established after a 2024 pilot program, during which every patient aged 65 and above underwent sarcopaenia screening under EWGSOP criteria. Those diagnosed received combined dietetic and physiotherapy support.

Shanley explained the hospital’s strategy of incorporating higher-protein meals tailored to older adults’ preferences and available food options. While the current system delivers positive outcomes, it lacks the ability to measure bone density or detect osteopaenia or osteoporosis, nor does it assess eligibility for bone-strengthening medications. The team is therefore refining the pathway to address these gaps.

Both presenters outlined that “probable sarcopaenia should prompt consideration of bone density assessment.” They also stated that “Early DXA scanning would help us identify osteopaenia or osteoporosis, initiate pharmacological treatment where appropriate, and reduce fractures, mortality, and long-term disability in a high-risk cohort.”

The updated pathway aims to integrate these improvements while maintaining its evidence-based, preventive focus. Aligned with national bone health strategies, the initiative seeks to enhance efficiency and reduce fracture-related costs.

Leave a Reply

Your email address will not be published. Required fields are marked *